Indication
High-Risk Myeloid Malignancies
1 clinical trial
1 product
Clinical trial
An Open-label, Multi-center, Phase I/II Study of MFA-370 in Patients With Metastatic Urothelial CancerStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Product
ECT-001-CB